All News #Library
Biotech
Inimmune Completes INI-2004 P2 Enrollment for Allergic Rhinitis
12 Mar 2026 //
PR NEWSWIRE
Inimmune Bolsters Leadership For INI-2004 Allergic Rhinitis
05 Mar 2026 //
PR NEWSWIRE
Inimmune Starts Key Ph 2 Trial of INI-2004 for Allergic Rhinitis
07 Jan 2026 //
PR NEWSWIRE BIO
INIMMUNE Reports Successful Phase 1 For Allergy Treatment INI-2004
15 May 2024 //
PR NEWSWIRE
Inimmune Collaborates with Boston Children`s Hospital to Develop Novel Adjuvants
24 Oct 2023 //
PR NEWSWIRE
Inimmune CSO Jay Evans to present an update on clinical stage programs
28 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support